1. Record Fiscal Q1 Revenue Sets Stage for the Year Ahead

First quarter fiscal 2026 revenue increased 22% to $10.9 million from $8.9 million last year – the strongest first quarter revenue on record for Roadzen, driven by growth in India and the U.S., along with the resumption of U.K. business opportunities.

2. Significantly Narrowed Net Loss and Fourth Straight Quarter of Adjusted EBITDA1 Improvement

Net loss narrowed to $(4.0) million from $(48.4) million in the first quarter last fiscal year, a 92% year-over-year improvement. Adjusted EBITDA loss improved to $(1.4) million from $(2.8) million the prior year — a 50% year-over-year improvement — marking the fourth consecutive quarter of sequential gains as the Company moves toward Adjusted EBITDA breakeven within this fiscal year.

3. Balance Sheet Strengthened Through Capital Raised at a Premium, Anchored by Roadzen's Major Shareholders in July

Subsequent to the fiscal Q1 end, in the last week of July 2025, Roadzen closed two securities purchase transactions totaling approximately $4.5 million. The first transaction was priced at $1.25 per share, a 20% premium to market and led by Roadzen's major shareholders; the second transaction was priced at $1.30 per share, both indicating strong investor confidence in the Company's trajectory.

NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Roadzen Inc. (NASDAQ:RDZN) ("Roadzen" or the "Company"), a global leader in AI at the convergence of insurance and mobility, today announced its financial results for the three-months ended June 30, 2025, its first quarter of fiscal year 2026.

"Roadzen delivered a record first quarter, with revenue up more than 22% year-over-year and our fourth consecutive quarter of improving Adjusted EBITDA, moving us significantly further along our path to breakeven," said Rohan Malhotra, CEO and founder of Roadzen. "Q1 is typically our slowest quarter of the year due to seasonality, so this level of growth marks an important inflection point for us. The foundation we've built — stronger operations, a cleaner balance sheet, and a robust global client base — positions us to deliver the best year in our history."

Malhotra continued, "We have multiple catalysts ahead, from the greenshoots in our U.K. business to regulatory tailwinds driving adoption of DrivebuddyAI in India, and expanding partnerships with some of the world's largest insurers, automakers, and fleets as they choose Roadzen to bring AI to their operations. We believe the value we're creating — through innovation, disciplined execution, and strategic growth — will be reflected in both our results and our market valuation. We ask investors to track three things this year: our growth on the path to breakeven, the continued strengthening of our balance sheet, and the innovations that reinforce our leadership as the leading AI company in insurance. This is a golden age of AI, and our mission is to power it — building solutions that transform the way mobility is insured worldwide."

"This quarter's results reflect the financial rigor and structural improvements we've worked hard to implement over the past year," said Jean-Noël Gallardo, Chief Financial Officer of Roadzen. "We've significantly reduced operating expenses and brought more predictability to our financial model—all while supporting growth in strategic areas. Through a combination of disciplined cost management and targeted capital raises, we now have a clear path to reach Adjusted EBITDA breakeven."

Mr. Gallardo added, "As our revenue base expands and costs remain controlled, we expect continued margin expansion and improved cash flow dynamics. We're focused on maintaining this momentum and delivering sustainable, long-term value for our shareholders."

First Fiscal Quarter 2026 Financial Highlights:

Revenue and Key Performance Indicators:

Operating Expenses:

Net Results:

Subsequent Financial Events:

First Quarter 2026 Operational Highlights

Product Advances and Patent Awards:

Contract Announcement:

Subsequent Fiscal 2026 Operational Developments

Contract and Partnership Announcements:

General Interest:

For more information about Roadzen Inc., please visit https://roadzen.ai/

About Roadzen Inc.

Roadzen Inc. (NASDAQ:RDZN) is a global technology company transforming auto insurance using advanced artificial intelligence (AI). Thousands of clients, from the world's leading insurers, carmakers, and fleets to dealerships and auto insurance agents, use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. Roadzen's pioneering work in telematics, generative AI, and computer vision has earned recognition as a top AI innovator by publications such as Forbes, Fortune, and Financial Express. Roadzen's mission is to continue advancing AI research at the intersection of mobility and insurance, ushering in a world where accidents are prevented, premiums are fair, and claims are processed within minutes, not weeks. Headquartered in Burlingame, California, the Company has 323 employees across its global offices in the U.S., U.K. and India. To learn more, please visit www.roadzen.ai.

Cautionary Statement Regarding Forward Looking Statements

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may," "should," "could," "would," "expect," "plan," "anticipate," "believe," "estimate," and "continue," or the negative of such terms or other similar expressions. Such statements include, but are not limited to, statements regarding the anticipated benefits of our products and solutions, anticipated benefits and revenues from the partnership described in this press release, business growth in the U.S., U.K. and India, anticipated Adjusted EBITDA breakeven timing, strategy, demand for our products, expansion plans, future operations, future operating results, estimated revenues, losses, projected costs, prospects, plans and objectives of management, as well as all other statements other than statements of historical fact included in this press release. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in "Risk Factors" in our Securities and Exchange Commission ("SEC") filings, including the annual report on Form 10-K we filed with the SEC on June 26, 2025. We urge you to consider these factors, risks and uncertainties carefully in evaluating the forward-looking statements contained in this press release. All subsequent written or oral forward-looking statements attributable to our company or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements. The forward-looking statements included in this press release are made only as of the date of this release. Except as expressly required by applicable securities law, we disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

For more information, please contact:

Investor Contacts: IR@roadzen.ai 

Media Contacts: Sanya Soni sanya@roadzen.ai or media@roadzen.ai


 ***Financial Statements Follow ***

Roadzen Inc.

Unaudited Condensed Consolidated Balance Sheets

(in US $, except share count)
       
  As of June 30,  As of March 31, 
Particulars 2025   2025 
Assets      
Current assets:        
Cash and cash equivalents  3,124,856   4,836,576 
Accounts receivable, net  2,574,592   2,625,385 
Inventories  99,187   202,535 
Prepayments and other current assets  21,167,240   19,092,595 
Investments  124,689   197,805 
Total current assets  27,090,564   26,954,896 
Non current assets        
Restricted cash  218,714   217,064 
Non marketable securities  269,470   269,470 
Property and equipment, net  633,015   602,923 
Goodwill  2,061,553   2,061,553 
Operating lease right-of-use assets  1,048,594   1,109,219 
Intangible assets, net  1,504,567   1,243,253 
Other long-term assets  130,822   120,972 
Total Non current assets  5,866,735   5,624,454 
Total assets  32,957,299   32,579,350 
         
Liabilities and shareholders' Equity/(Deficit)        
Current liabilities        
Current portion of long-term borrowings  2,912,746   2,904,444 
Short-term borrowings  20,591,106   19,865,645 
Accounts payable and accrued expenses  32,822,637   30,254,010 
Derivative warrant liabilities  1,535,869   1,489,818 
Short-term operating lease liabilities  442,914   318,921 
Other current liabilities  2,304,421   2,102,466 
Total current liabilities  60,609,693   56,935,304 
Non current liabilities        
Long-term borrowings  150,334   139,775 
Long-term operating lease liabilities  443,500   628,400 
Other long-term liabilities  547,523   566,651 
Total Non current liabilities  1,141,357   1,334,826 
Total liabilities  61,751,050   58,270,130 
         
Commitments and contingencies (refer note 21)        
         
Shareholders' Equity/(Deficit)        
Ordinary Shares and additional paid in capital, $0.0001 par value per share, 220,000,000 shares authorized as of June 30, 2025 and March 31, 2025; 74,290,986 shares outstanding as of June 30, 2025 and March 31, 2025  96,888,250   95,501,291 
Accumulated deficit  (227,832,212)  (223,826,442)
Accumulated other comprehensive income/(loss)  (929,924)  (468,859)
Other components of equity  103,791,466   103,720,113 
Total shareholders' deficit  (28,082,420)  (25,073,897)
Non-controlling interest  (711,331)  (616,883)
Total deficit  (28,793,751)  (25,690,780)
Total liabilities and Total Deficit  32,957,299   32,579,350 
         



Roadzen Inc.

Unaudited Condensed Consolidated Statements of Operations

(in US $, except share count)
         
  For the three months ended

June 30,
 
Particulars 2025  2024 
Revenue  10,865,545   8,931,517 
Costs and expenses:        
Cost of services  4,469,453   5,427,440 
Research and development  81,534   1,789,542 
Sales and marketing  6,132,010   5,802,298 
General and administrative  2,577,897   25,826,188 
Depreciation and amortization  125,000   480,349 
Total costs and expenses  13,385,894   39,325,817 
Loss from operations  (2,520,349)  (30,394,300)
Interest expense (net)  (941,319)  (821,686)
Fair value gains/(losses) in financial instruments carried at fair value  (511,538)  (17,152,060)
Other income (net)  (47,922)  22,352 
Total other income/(expense)  (1,500,779)  (17,951,394)
(Loss)/Income before income tax expense  (4,021,128)  (48,345,694)
Less: income tax (benefit)/expense  79,979   106,650 
Net (loss)/income before non-controlling interest  (4,101,107)  (48,452,344)
Net loss attributable to non-controlling interest, net of tax  (95,337)  (45,319)
Net Loss attributable to Ordinary shareholders  (4,005,770)  (48,407,025)
Net loss per share attributable to Ordinary shareholders        
Basic and Diluted  (0.05)  (0.71)
Weighted-average number of shares used in computing net loss per share (Basic and Diluted)  74,290,986   68,440,829 
         



Roadzen Inc.

Unaudited Condensed Consolidated Statements of Cash Flow

(in US $, except share count)
       
  For the Period ended

June 30,
 
Particulars 2025  2024 
       
Cash flows from operating activities        
Net loss per share attributable to Ordinary shareholders  (4,005,770)  (48,407,025)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization  125,000   480,349 
Stock based compensation  71,358   26,230,989 
Deferred income taxes  (1,289)  (37,185)
Unrealized foreign exchange loss/(profit)  (9,456)  (3,398)
Fair value losses in financial instruments carried at fair value  511,538   17,152,060 
Expected credit loss (net of reversal)  198,749   (50,682)
Net loss attributable to non-controlling interest, net of tax  (95,337)  (45,319)
Changes in assets and liabilities, net of assets acquired and liabilities assumed from acquisitions:        
Inventories  103,415   (6,803)
Accounts receivables, net  (147,930)  1,037,883 
Prepayments and other assets  (2,071,468)  1,046,454 
Accounts payable and accrued expenses  2,323,205   (2,767,021)
Other liabilities  76,478   (296,982)
Net cash used in operating activities  (2,921,507)  (5,666,680)
         
Cash flows from investing activities        
Purchase of property and equipment, intangible assets and goodwill  (274,056)  32,745 
Proceeds from sale of mutual fund  73,116   193,606 
Proceeds from forward purchase agreement  -   1,000,000 
Net cash used in investing activities  (200,940)  1,226,351 
         
Cash flows from financing activities        
Proceeds from issue of ordinary shares  1,386,959   - 
Net proceeds/(payments) from borrowings  49,990   - 
Repayments of long-term borrowings  -   (121,365)
Net proceeds/(payments) from short-term borrowings  -   1,154,519 
Net cash generated from financing activities  1,436,949   1,033,154 
Effect of exchange rate changes on cash and cash equivalents  (24,586)  (3,519)
Net (decrease)/increase in cash and cash equivalents (including restricted cash)  (1,710,084)  (3,410,694)
Cash and cash equivalents at the beginning of the period (including restricted cash)  5,053,654   11,565,088 
Cash and cash equivalents at the end of the period (including restricted cash)  3,343,570   8,154,394 
Reconciliation of cash and cash equivalents        
Cash and cash equivalents  3,124,856   7,777,413 
Restricted cash  218,714   376,981 
Total cash and cash equivalents  3,343,570   8,154,394 
         
Supplemental disclosure of cash flow information        
Cash paid for interest, net of amounts capitalized  1,001,397   391,829 
Non-cash investing and financing activities        
Consideration payable in connection with acquisitions  8,376,253   488,000 
Interest accrued on borrowings  2,089,465   790,395 
         

Non-GAAP Financial Measures

This press release includes Adjusted Earnings Before Interest, Tax, Depreciation and Amortization ("Adjusted EBITDA"), a non-GAAP financial measure which excludes the impact of finance costs, taxes, depreciation and amortization and certain other items from reported net profit or loss. We believe that Adjusted EBITDA aids investors by providing an operating profit/loss without the impact of non-cash depreciation and amortization and certain non-recurring and other items to help clarify sustainability and trends affecting the business. For comparability of reporting, management considers non-GAAP measures in conjunction with U.S. GAAP financial results in evaluating business performance. Adjusted EBITDA should not be considered a substitute for, or superior to, the measures of financial performance prepared in accordance with U.S. GAAP. In addition, Adjusted EBITDA does not purport to represent cash flows provided by, or used for, operating activities in accordance with GAAP and should not be used as a measure of liquidity.

Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as substitutes for financial information presented under GAAP. There are a number of limitations related to the use of non-GAAP financial measures versus comparable financial measures determined under GAAP. For example, other companies in our industry may calculate these non-GAAP financial measures differently or may use other measures to evaluate their performance. These limitations could reduce the usefulness of these non-GAAP financial measures as analytical tools. Investors are encouraged to review the related GAAP financial measures and the reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial measures and to not rely on any single financial measure to evaluate our business.

The following table reconciles our net loss reported in accordance with U.S. GAAP to Adjusted EBITDA:

  For the three months ended

June 30,
 
Particulars 2025  2024 
Net loss (Including Non Controlling Interest)  (4,005,770)  (48,407,025)
Adjusted for:        
Other (income)/expense net  47,922   (22,352)
Interest (income)/expense  941,319   821,686 
Fair value changes in financial instruments carried at fair value  511,538   17,152,060 
Tax (benefit)/expense  79,979   106,650 
Depreciation and amortization  125,000   480,349 
Stock based compensation expense  71,358   26,230,989 
Non-cash expenses  306,714   285,060 
Non-recurring expenses  516,102   524,758 
Adjusted EBITDA  (1,405,838)  (2,827,825)




1 Adjusted EBITDA is a non-GAAP financial metric. See "Non-GAAP Financial Measures" at the end of this press release for more information, including a reconciliation to the nearest GAAP financial measure.



Primary Logo